Dahlqvist Per, Spencer Rupert, Marques Pedro, Dang Mary N, Glad Camilla A M, Johannsson Gudmundur, Korbonits Márta
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, and Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg SE-413 45, Sweden.
Department of Public Health and Clinical Medicine, Umeå University, Umeå SE-901 85, Sweden.
J Endocr Soc. 2017 Jul 14;1(8):1104-1109. doi: 10.1210/js.2017-00164. eCollection 2017 Aug 1.
Acromegaly is usually not a difficult condition to diagnose once the possibility of this disease has been raised. However, a few conditions present with some aspects of acromegaly or gigantism but without growth hormone (GH) excess. Such cases are described as "pseudoacromegaly" or "acromegaloidism". Here we describe a female patient investigated for GH excess at 10 years of age for tall stature since infancy (height and weight > +3 standard deviations) and typical acromegalic features, including large hands/feet, large jaw, tongue, hoarse deep voice, and headache. Results of radiography of the sella turcica and GH response at an oral glucose tolerance test and insulin-arginine- thyrotrophin-luteinizing hormone-releasing hormone test were normal. Ethinylestradiol and medroxyprogesterone were given for 2 years; this successfully stopped further height increase. Although the patient's growth rate plateaued, coarsening of the facial features and acral enlargement also led to investigations for suspicion of acromegaly at 23 and 36 years of age, both with negative results. On referral at the age of 49 years, she had weight gain, sweating, sleep apnea, headaches, joint pain, and enlarged tongue. Endocrine assessment again showing normal GH axis was followed by genetic testing with a macrocephaly/overgrowth syndrome panel. A mutation in the gene (c.6605G>C; p.Cys2202Ser) was demonstrated. Mutations affecting the same cysteine residue have been identified in patients with Sotos syndrome. In summary, Sotos syndrome and other overgrowth syndromes can mimic the clinical manifestations of acromegaly or gigantism. Genetic assessment could be helpful in these cases.
一旦考虑到肢端肥大症这种疾病的可能性,通常不难诊断。然而,有一些病症虽表现出肢端肥大症或巨人症的某些方面,但并无生长激素(GH)分泌过多。此类病例被描述为“假性肢端肥大症”或“肢端肥大样症”。在此,我们描述一名女性患者,她自婴儿期起就身材高大(身高和体重超过+3个标准差),具有典型的肢端肥大症特征,包括大手/大脚、大下巴、舌头、声音嘶哑低沉以及头痛,10岁时因GH分泌过多接受检查。蝶鞍X线检查结果以及口服葡萄糖耐量试验和胰岛素 - 精氨酸 - 促甲状腺素 - 促黄体生成素释放激素试验中的GH反应均正常。给予乙炔雌二醇和甲羟孕酮治疗2年;这成功阻止了身高的进一步增长。尽管患者的生长速度趋于平稳,但面部特征变粗和肢端增大仍导致在23岁和36岁时因疑似肢端肥大症而接受检查,结果均为阴性。49岁转诊时,她出现体重增加、多汗、睡眠呼吸暂停、头痛、关节疼痛和舌头肿大。内分泌评估再次显示GH轴正常,随后使用巨头症/过度生长综合征检测板进行基因检测。发现基因发生了一个突变(c.6605G>C;p.Cys2202Ser)。在患有索托斯综合征的患者中已鉴定出影响相同半胱氨酸残基的突变。总之,索托斯综合征和其他过度生长综合征可模仿肢端肥大症或巨人症的临床表现。在这些病例中,基因评估可能会有所帮助。